CLRB icon

Cellectar Biosciences
CLRB

Overview Fund Trends Analyst Outlook Journalist POV

19 hedge funds and large institutions have $2.43M invested in Cellectar Biosciences in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

Holders
19
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$15.2K
2
+$647

Top Sellers

1
-$284K
2
-$31.9K
3
-$17.7K
4
TRCT
Tower Research Capital (TRC)
New York
-$4.97K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$1.12K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$1.34M
2
$485K
3
$251K
4
$82K
5
$81.6K
6
$68K
7
$35.8K
8
$22.6K
9
$21.4K
10
$20.5K
11
$17.2K
12
$7K
13
$3.02K
14
$745
15
$408
16
$80
17
$57
18
$26
19
$4
20
–
21
–
22
–
23
–
24
–
25
–